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Clinical Report
 INTRODUCTION
Labyrinthine injuries are some of the most frequent causes of vertigo and alterations of balance. An acute damage of the posterior 
labyrinth usually causes rotational vertigo, although sometimes, the absence of compensation may cause a persistent instability. 
When both labyrinths are simultaneously damaged, the predominant symptom from the beginning is instability, which may be-
come severe and impair the ability of patients to perform their daily activities [1].
Causes of bilateral vestibulopathy are varied and not always easy to be identified and include Menière’s disease, CANVAS syndrome 
(cerebellar ataxia with neuropathy and vestibular areflexia syndrome), meningitis, and ototoxicity. It is well known that ototoxicity 
is caused by aminoglycoside antibiotics [2, 3]. However, ototoxic effects induced by other drugs, such as salicylates, some chemother-
apeutic agents, other non-aminoglycoside antibiotics, or sildenafil, have also been reported. Thus far, most studies on drug-induced 
ototoxicity focus on the cochleotoxic effect, while reports on the vestibulotoxic effect are relatively rare [4-10]. This fact may be due to 
several reasons. Cochlear damage can be evaluated (by audiometric tests) easier than vestibular damage (clinical examination and 
measurement of vestibular function make use of instruments not available in all hospitals). Cochlear damage usually is permanent 
with an irreversible hearing loss, while, in many patients with vestibulotoxicity, imbalance can remain inadvertent. Patients may 
accept vestibular symptoms as part of their disease and impairment of their general status. Compensatory mechanisms provided 
by other afferent signals (visual and proprioceptive) can contribute to ameliorate the clinical perception of vestibular symptoms.
It is likely that vestibulotoxicity is underestimated by clinicians. Drug-induced ototoxic damage on the posterior labyrinth frequent-
ly causes an important imbalance with an impairment in the quality of life. Thus, it becomes relevant to recognize, evaluate, and 
quantify an imbalance secondary to vestibulotoxicity. A high index of suspicion is required to avoid that the diagnosis of vestibulo-
toxicity will be overlooked and to ensure an adequate treatment (such as vestibular rehabilitation) to improve patient equilibrium.
The objective of this study is to report different causes of vestibulotoxicity in patients with instability.
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Instability Due to Drug-Induced Vestibulotoxicity
OBJECTIVE: The therapeutic use of ototoxic drugs is relatively common, particularly in patients with severe diseases. It is likely that disturbances 
of balance in these patients are underestimated by clinicians. 
MATERIALS and METHODS: The purpose of this study was to identify drugs involved in the vestibulotoxic origin of instability in a group of 18 
patients. 
RESULTS: Six patients showed both cochlear and vestibular damage, while 12 were affected only by posterior labyrinthine damage. Four groups of 
drugs were identified: antibiotics (nine patients), cytostatics (four), anti-tuberculosis medicinal products (three), and other drugs (two). Cytostatics 
were involved in many cases studied, a fact scarcely reported before. 
CONCLUSION: It is important to ensure an early diagnosis to prevent ototoxic effects induced by drugs. We propose that patients receiving 
potential ototoxic drugs undergo cochlear and vestibular assessments. Further, we recommend that patients with instability undergo vestibular 
rehabilitation.
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MATERIALS and METHODS
A prospective study in patients diagnosed with chronic imbalance 
due to drug-induced vestibulotoxicity was performed. Patients 
who were diagnosed in a Neurotology Unit of a tertiary hospital 
(Complexo Hospitalario Universitario de Santiago de Compostela, 
Spain) over 16 years (from 1999 to 2014) were included. The study 
was approved by the local Independent Ethics Committee, and all 
patients granted their informed consent to participate in it. All pa-
tients underwent the following protocol:
• A complete history (it is necessary to exclude other possible 
causes of symptoms and signs observed).
• Clinical examination of vestibular function, particularly tests 
that allow suspecting vestibular labyrinthine damage (spon-
taneous nystagmus with and without fixation of gaze, Hal-
magyi test, head-shaking test, Romberg test, and Unterberg-
er test).
• Pure tone audiometry: Determination of auditory thresholds 
for pure tones at 125, 250, 500, 1000, 2000, 3000, 4000, and 
8000 Hz. For this purpose, an audiometer (AUDIOTEST model 
340, Interacoustic, Italy), with its own earphones, was used.
• Sensory organization test (SOT) of computerized dynamic pos-
turography (CDP) performed using Neurocom Smart Equitest® 
and Neurocom Smart Balance Master® (Clackamas; Oregon, 
USA): Recording and measuring of changes in the patient’s dis-
tribution of weight were obtained under six different sensory 
conditions (condition 1: immobile surface, immobile visual sur-
round, eyes open; condition 2: immobile surface, eyes closed; 
condition 3: immobile surface, mobile visual surround, eyes 
open; condition 4: mobile surface, immobile visual surround, 
eyes open; condition 5: mobile surface, eyes closed; and condi-
tion 6: mobile surface, mobile visual surround, eyes open). This 
test allows measuring the total balance of patients and ana-
lyzing the contribution of each of the three sensory systems 
(somatosensory, visual, and vestibular) involved.
• Recording of spontaneous nystagmus and caloric-induced 
nystagmus. The recording and measuring of nystagmus were 
performed by electronystagmography (Nystar plus electro-
nystagmograph) or videonystagmography (two videonystag-
mographs were used: VIDEONYSTAGMOGRAPHIE VEONYS IMV 
Biodigital model and HIS model, France). Patients underwent 
caloric stimulation with hot (44°C) and cold (30°C) water by ap-
plying the following sequence: Hot water in the right ear, hot 
water in the left ear, cold water in the right ear, and cold water 
in the left ear. Unilateral vestibular hypofunction was consid-
ered when the two ears showed an asymmetrical response 
(obtained by applying Jongkees formula at the maximal slow-
phase velocity of the nystagmic response) of at least 25%. 
Bilateral vestibular hypofunction was considered when the 
addition of the maximal slow-phase velocity of the nystagmic 
response from the four stimuli was lower than 20°/s.
The inclusion criteria were as follows:
• Absence of a history of balance disorders before starting oto-
toxic drug administration.
• Acute onset of dizziness or imbalance during or just after oto-
toxic drug administration.
• Persistent symptoms for at least three months.
• Disequilibrium confirmed by abnormal dynamic posturo-
graphic results (SOT): A value of the average balance score of 
less than 68 and a deficit of at least the vestibular information 
input.
• Labyrinthine lesion demonstrated by one of the following data:
- Presence of spontaneous or postheadshake nystagmus
- Uni-or bilateral saccades as a response to the Halmagyi 
test
- Uni-or bilateral hypofunction observed by the nystagmo-
graphic recording of caloric tests
The following exclusion criteria were considered:
• Presence of any other disease that would justify the symptoms
• Spontaneous disappearance of symptoms in less than three 
months
• Patients unable to undergo dynamic posturography because 
of their inability to remain in the standing position without 
support
• Patients unable to undergo caloric tests in good conditions 
(e.g., some diseases affecting middle and/or outer ear may 
contraindicate a stimulation with water, or, in some ophthal-
mologic diseases, a normal nystagmographic recording is not 
possible).
• Refusal of the patient to perform any of the above mentioned tests
Variables obtained from each patient were as follows:
• Sex
• Age when diagnosis was established
• Type of affectation (cochleovestibular or exclusively vestibular)
• Drug involved
• Previous pathology treated with a vestibulotoxic drug
• Symptoms reported by patients
• Pure tone audiometry
• SOT of CDP: Average balance score and evaluation of the con-
tribution of sensory inputs
• Caloric tests: Normal, unilateral, or bilateral hypofunction, ab-
sent response uni- or bilaterally
• Treatment
• Evolution of symptoms
Data from patients were entered into a database created for this 
purpose. 
RESULTS
There were 18 patients (11 women and 7 men). The mean age was 
60.2 years (standard deviation: 16.41; range: 21–78 years). Six of 
them showed both cochlear and vestibular damage, while 12 were 
affected only by posterior labyrinthine damage.
With regard to the drug involved in toxicity, four groups can be 
identified:
• Antibiotics (nine patients). Eight patients received systemic 
gentamicin alone (two patients) or associated to vancomycin 
(five) or to metronidazole (one patient). The remaining patient 
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received amoxicillin/clavulanic acid and azithromycin. Clinical 
data are shown in Table 1.
• Cytostatics (four patients): The drugs administered to and clin-
ical data of these patients are shown in Table 2.
• Anti-tuberculosis medicinal products (three patients): Ethambu-
tol, plus either pyrazinamide and isoniazid, or rifampicin.
• Other drugs: One patient received tamoxifen (for the treatment 
of breast cancer) and another received melphalan (therapy for 
amyloidosis).
The clinical data for these last two groups of patients are shown in 
Table 3.
The symptom reported by all studied patients was instability, which 
showed different patterns:
• In six patients, the instability perception was continuous.
• Eleven patients complained of instability when they were on 
foot and walking.
Table 1. Clinical data of patients with instability due to antibiotics
        Spontaneous  Sensory
        nystagmus or Videonystag organization
   Cochlear Main   Pure tone saccades in the mography test (dynamic Treatment of Clinical
Case Sex Age damage disease Antibiotics Symptoms audiometry Halmagyi test  (caloric tests) posturography) instability course
1 M 78 Absent Pneumonia Amoxicillin/ Instability Moderate Absent Bilateral Average: 62 No treatment Return 
     clavulanic acid  when sensorineural  hyporeflexia Pattern:  to the 
     and azithromycin walking hearing    vestibular  normal 
       loss at high    deficit  status 
       frequencies     
2 M 70 Absent Endocarditis Gentamicin and  Instability Moderate Absent Bilateral Average: 63 Vestibular Remarkable 
     vancomycin when walking  sensorineural  hyporeflexia Pattern: rehabilitation: improvement 
      and oscillopsia hearing loss    vestibular dynamic 
       at high    deficit posturography 
       frequencies     
3 F 62 Absent Peritonitis Gentamicin and  Continuous Moderate Absent Bilateral Average: 66 Walking Return 
     vancomycin instability sensorineural   hyporeflexia Pattern:  to the 
       hearing loss    vestibular  normal 
       at high    deficit  status 
       frequencies     
4 M 62 Present Defibrillator  Gentamicin and Instability Severe Absent Bilateral Average: 64 Vestibular Return 
    infection vancomycin when walking sensorineural   hyporeflexia Pattern: rehabilitation: to the 
       hearing loss    vestibular dynamic normal 
       at high    and visual posturography status 
       frequencies   deficits  
5 F 76 Present Infected  Gentamicin Instability Moderate Absent Bilateral Average: 49 Walking Mild 
    elbow fracture  when walking  sensorineural  areflexia Pattern:  improvement 
      and worsening  pantonal   vestibular 
      of hearing loss bilateral    and visual 
       hearing loss    deficits  
6 M 58 Absent Endocarditis Gentamicin  Instability Normal Absent Bilateral Average: 52 Vestibular Remarkable 
     and vancomycin when walking   areflexia Pattern:  rehabilitation: improvement 
          vestibular and  dynamic 
          visual deficits posturography 
7 F 78 Absent Peritonitis Gentamicin  Continuous Moderate Absent Bilateral Average: 29 Vestibular: Mild 
     and metronidazole instability sensorineural   areflexia Pattern: rehabilitation: improvement 
       hearing loss    vestibular and dynamic 
       at high    visual deficits posturography 
       frequencies     
8 M 62 Absent Defibrillator Gentamicin Continuous Moderate Absent Bilateral Average: 29 Vestibular Remarkable 
    infection  instability sensorineural   hyporeflexia Pattern: rehabilitation:  improvement 
       hearing loss    somatosensory, dynamic 
       at high    vestibular, and posturography 
       frequencies   visual deficits  
9 F 78 Present Dialysis  Gentamicin Continuous Profound Absent Bilateral Average: 28 No treatment 
    catheter  and vancomycin instability and bilateral  hyporeflexia Pattern: (exitus) 
    infection  worsening of  hearing loss   vestibular and 
      hearing loss    visual deficits
M: male; F: female
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• In the remaining patient, instability was discontinuous, being 
more intense in the morning.
In 13 patients, instability was the only symptom reported. The re-
maining five patients complained of other concomitant symptoms 
such as oscillopsia (two), bilateral tinnitus (two), and hearing loss (or 
exacerbation of a previous hearing loss) (two).
Six patients had normal pure tone audiometry results, while 12 had 
sensorineural hearing loss:
• A high-frequency hearing loss in 10 patients
Table 2. Clinical data of patients with instability due to cytostatics 
        Spontaneous  Sensory
        nystagmus or Videonystag organization
   Cochlear Main   Pure tone saccades in the mography test (dynamic Treatment of Clinical
Case Sex Age damage disease Drug(s) Symptoms audiometry Halmagyi test  (caloric tests) posturography) instability course
10 M 34 Absent Hodgkin’s  Vinblastine, Instability Normal Absent Bilateral Average: 66 Walking Return 
    disease adriamycin,  when   hyporeflexia Pattern:  to the 
     DTIC, and  walking    vestibular  normal 
     bleomycin      deficit  status
11 F 58 Absent Breast  Docetaxel Continuous Normal Absent Bilateral Average: 62 Walking Mild 
    carcinoma and  instability   hyporeflexia Pattern:  improvement 
     cyclophosphamide     vestibular deficit  
12 F 50 Present Lung  CDDP+VNB Continuous Moderate Absent Bilateral Average: 26 Vestibular Remarkable 
    carcinoma  instability,  sensorineural  areflexia Pattern: rehabilitation: improvement 
      oscillopsia,  hearing   somatosensory, dynamic 
      and tinnitus loss at high    vestibular, and posturography 
       frequencies   visual deficits  
13 F 67 Present Carcinoid  111In-DTPA- Instability Severe Absent Bilateral Average: 52 Walking Remarkable 
    tumor octreotide when walking sensorineural   hyporeflexia Pattern:  improvement 
       hearing loss    vestibular and 
       at high frequencies   visual deficits  
M: male; F: female; DTIC: dacarbazine; CDDP: cisplatin; VNB: vinorelbine; DTPA: diethylenetriaminepentaacetic acid
Table 3. Clinical data of patients with instability due to anti-tuberculosis drugs, tamoxifen, and melphalan
        Spontaneous  Sensory
        nystagmus or Videonystag organization
   Cochlear Main   Pure tone saccades in the mography test (dynamic Treatment of Clinical
Case Sex Age damage disease Drug(s) Symptoms audiometry Halmagyi test  (caloric tests) posturography) instability course
14 M 71 Absent Disseminated  Ethambutol, Instability Moderate Absent Bilateral Average: 57 Walking Remarkable 
    tuberculosis pyrazinamide,  when walking sensorineural  areflexia Pattern:  improvement 
     and isoniazid  hearing loss    vestibular 
       at high frequencies   deficit 
15 F 21 Absent Disseminated  Ethambutol, Instability Normal Absent Bilateral Average: 53 No treatment Return 
    tuberculosis streptomycin,  when walking   hyporeflexia Pattern:  to the 
     and rifampicin     vestibular and   normal 
          visual deficits  status
16 F 40 Absent Pulmonary  Ethambutol, Instability Normal Absent Bilateral Average: 63 No treatment Remarkable 
    tuberculosis pyrazinamide,  when walking   hyporeflexia Pattern:  improvement 
     and isoniazid     vestibular and  
          visual deficits  
17 F 46 Absent Breast  Tamoxifen Discontinuous Normal Absent Bilateral Average: 51 No treatment Return 
    carcinoma  instability    hyporeflexia Pattern:  to the 
      (more intense     vestibular and  normal 
      in the morning)    visual deficits  status
18 F 76 Present Amyloidosis Melphalan Instability  Severe Absent Bilateral Average: 60 Walking Remarkable 
      when walking  sensorineural  hyporeflexia Pattern:  improvement 
      and tinnitus hearing loss    vestibular and 
       at high    visual deficits 
       frequencies     
M: male; F: female
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• A profound bilateral hearing loss in one patient
• A mild hearing loss in all frequencies in the remaining patient.
All patients had an abnormal SOT on CDP. The SOT average balance 
score was 52.33 (SD: 14.88). With regard to the posturographic pat-
tern, six patients showed a pure vestibular-deficient type, 10 showed 
a somatosensory-dependent pattern (with visual and vestibular defi-
cits), and the remaining two had all inputs affected (somatosensory, 
visual, and vestibular).
None of the patients had spontaneous nystagmus or saccades with 
the oculocephalic maneuver (Halmagyi test). Caloric tests were bilat-
erally affected in all patients. Reduced (13 patients) or absent (five) 
caloric responses were demonstrated. 
With regard to treatment, five patients did not receive treatment (four 
of them experienced a spontaneous improvement in their symptoms 
and one died as consequence of a previous illness). The remaining 13 
patients underwent therapeutic vestibular rehabilitation:
• Seven patients: Walking and performing home vestibular re-
training exercises
• Six patients: Undergoing instrumental vestibular rehabilitation 
by dynamic posturography
In the majority of patients, the clinical course was good. Only three 
patients complained of persistent problems of instability with hand-
icapping effects. In the remaining patients, symptoms markedly im-
proved because of vestibular rehabilitation exercises.
DISCUSSION
The use of ototoxic drugs is relatively common, particularly in pa-
tients with severe potentially life-threatening diseases (including 
malignant tumors and severe infections). In such cases, it is assumed 
that the risk of not using these drugs is greater than the risk of their 
potential ototoxic effects. Due to an impaired general clinical status 
of many of these patients, the disturbances of balance consistent 
with posterior labyrinthine toxic damage can remain inadvertent or 
be attributed to other causes. Thus far, most studies on drug-induced 
ototoxicity are limited to the cochleotoxic effect, while reports on the 
vestibulotoxic effect are relatively rare.
In many cases, pharmacological treatment includes some drugs, so 
it becomes difficult to elucidate which of these compounds is the 
cause of ototoxicity. The mechanisms of action of some of them are 
known. Aminoglycosides are capable of stimulating the formation of 
reactive oxygen species that play an important role in inner ear dam-
age. This damage is ameliorated by the presence of free radical scav-
engers [11]. The presence of nitric oxide synthase was demonstrated in 
the vestibular epithelium. Nitric oxide may contribute to the induc-
tion of apoptosis in vestibular hair cells due to aminoglycosides [12].
Labyrinthine damage induced by other drugs has also been reported 
[4-10, 13]. This is the case for cisplatin, a chemotherapeutic agent that 
causes vestibular dysfunction. In animal models, cisplatin induc-
es vestibulotoxicity by altering ATPase activities (cisplatin inhibits 
ATPase activities) and increasing oxidative stress in labyrinths [13]. 
It is well known that glutathione and glutathione-related enzymes 
protect against oxidative cell injury caused by free radicals. Specific 
changes in glutathione levels and enzymes in glutathione metabo-
lism have been found with cisplatin treatment [14]. These findings are 
in agreement with the proposed mechanism of action based on ox-
idative stress.
We focused our attention on the fact that the vestibulotoxic potential 
of cytostatics has scarcely been studied. Their cochleotoxic potential 
has been reported in some studies, not so the vestibular damage 
[5, 10, 13, 15-17]. It is remarkable that vestibulotoxicity and cochleotoxicity 
do not always simultaneously occur. In our series of 18 patients, only 
one-third of them experienced symptoms consistent with cochlear 
affectation. This absence of auditory damage in many patients might 
also explain that vestibular damage remains undetected as patients 
and physicians ascribe imbalance to other causes. The finding of a 
normal auditory function does not imply that vestibular function is 
also unimpaired [3].
However, we consider important to detect this type of damage. 
Nowadays, neurotology provides us with a battery of diagnostic 
methods that allow us to confirm balance disorders (e.g., dynamic 
posturography) and assess the labyrinthine damage (e.g., Halmagyi 
test, videonystagmographic record of spontaneous nystagmus, and 
caloric tests). Once damage occurred, many patients experienced a 
spontaneous improvement of symptoms, explained by the contribu-
tion of other body systems (visual and proprioceptive) to the main-
tenance of balance. These inputs are usually able to compensate the 
affected vestibular function. In cases where this compensation is not 
achieved, therapeutic strategies (such as vestibular rehabilitation) 
can be applied to stimulate and increase this compensation. Vestib-
ular rehabilitation is particularly useful in elderly people because in 
these patients, compensation mechanisms are weakened and less 
effective [18].
We propose that patients with instability undergo vestibular reha-
bilitation to reduce the clinical effects of vestibulotoxicity. In addi-
tion, it is important to ensure an early diagnosis and prevent this 
ototoxicity. Suspicion by clinicians is key to recognize the symp-
toms and signs of posterior labyrinthine damage. In these cases, 
the immediate discontinuance of vestibulotoxic drug administra-
tion and its replacement by other non-vestibulotoxic drugs are the 
best chance to avoid damage to the inner ear. However, there are 
patients with severe diseases where the cessation of drug admin-
istration is not possible. Different studies have suggested that the 
co-administration of substances with protective effects against 
drug-induced vestibulotoxicity in such patients reduces the ad-
verse effects of treatment [19-21].
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